GSK plc (LSE:GSK) Annual Report 2021



The latest annual report of GSK plc (GSK) was published on 31 Dec 2021. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - GSK Annual Results

Amounts in GBP

Total Revenue
34.11B
Gross Profit
22.66B
EBIT
7.97B
Net Tangible Assets
-25.58B
Net Income
4.38B
Capital Expenditures
-1.17B

GSK Income Statement 2021 Annual Report

As per the latest Income Statement of GSK, the Net revenue increased by £15.00M (0%) compared to the previous period. The operating income in 2021 decreased by £-469.00M (-6%). The net income as per the annual report was 4.38B which decreased by £-1.364B (-24%) compared to previous year.

Income Statement Report (2021/2020)

2021 2020
Total Revenue 34.11B 34.1B
Gross Profit 22.66B 23.21B
Operating Income 7.97B 8.44B
Income Before Tax 5.44B 6.97B
Net Income 4.38B 5.75B

Balance Sheet - GSK 2021 Annual Report

Read further: GSK Balance Sheet Detailed Analysis

The latest balance sheet from annual result of GSK plc showed the company reduced the cash on balance sheet by £-2.018B (-32%). The Net tangible assets of GSK on the balance sheet were at -25.58B which is £258.00M (1%) more than previous annual report. The total stockholder equity also increased by £468.00M (3%) compared to previous reporting period.

Balance Sheet Statement Report (2021/2020)

2021 2020
Cash 4.27B 6.29B
Total Assets 79.1B 80.43B
Long Term Debt 19.76B 22.54B
Total Liabilities 57.76B 59.62B
Total Shareholder Equity 15.05B 14.59B
Net Tangible Assets -25.58B -25.83B

Cash Flow Statement - GSK 2021 Annual Report

The 2021 annual cash flow statement of GSK plc showed that the net income decreased by £-1.364B (-24%) compared to previous reporting period. Also the capital expenditure of GSK increased by £54.00M (4%).

As of 2021, the total cash from investing activities was -1.78B and total cash from financing activities was -7.59B.

Cash Flow Statement Report (2021/2020)

2021 2020
Net Income 4.38B 5.75B
Capital Expenditures -1.17B -1.23B
Dividends Paid -4B -3.98B
Total Cash From From Investing Activities -1.78B 2.16B
Total Cash From From Financing Activities -7.59B -10.13B

GSK plc Annual Report History

Income Statement

Income Statement history of GSK plc (LSE:GSK)

31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Total Revenue 34.11B 34.1B 33.75B 30.82B
Cost Of Revenue 11.45B 10.89B 10.79B 9.71B
Gross Profit 22.66B 23.21B 22.96B 21.11B
Research Development 4.88B 4.68B 4.41B 3.8B
Selling General Administrative 10.19B 10.5B 10.96B 9.5B
Non Recurring - - - -
Other Operating Expenses -373M -407M -606M 313M
Total Operating Expenses 26.15B 25.66B 25.55B 23.33B
Operating Income 7.97B 8.44B 8.2B 7.5B
Total Other Income Expense Net -2.52B -1.47B -1.98B -2.69B
Ebit 7.97B 8.44B 8.2B 7.5B
Interest Expense -775M -860M -877M -756M
Income Before Tax 5.44B 6.97B 6.22B 4.8B
Income Tax Expense 346M 580M 953M 754M
Minority Interest 6.29B 6.22B 6.95B -109M
Net Income From Continuing Ops 5.1B 6.39B 5.27B 4.05B
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income 4.38B 5.75B 4.64B 3.62B
Net Income Applicable To Common Shares 4.38B 5.75B 4.64B 3.62B

Balance Sheet Statement

Balance Sheet Statement history of GSK plc (LSE:GSK)

31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Cash 4.27B 6.29B 4.71B 3.87B
Short Term Investments 614M 480M 786M 419M
Net Receivables 7.48B 6.86B 6.44B 5.95B
Inventory 5.78B 6B 5.95B 5.48B
Other Current Assets 133M 195M 941M 658M
Total Current Assets 18.67B 20.25B 19.49B 16.93B
Long Term Investments 2.28B 3.5B 2.28B 1.56B
Property Plant Equipment 10.67B 11.01B 11.31B 11.06B
Good Will 10.55B 10.6B 10.56B 5.79B
Intangible Assets 30.08B 29.82B 30.95B 17.2B
Other Assets 6.85B 5.26B 5.09B 5.53B
Deferred Long Term Asset Charges 5.22B 4.29B 4.1B 3.89B
Total Assets 79.1B 80.43B 79.69B 58.07B
Accounts Payable 4.54B 4.36B 4.14B 3.65B
Short Long Term Debt 2.69B 2.45B 1.71B 1.37B
Other Current Liab 5.56B 5.4B 4.78B 5.23B
Long Term Debt 19.76B 22.54B 22.58B 20.23B
Other Liab 13.52B 14.05B 13.7B 11.63B
Minority Interest 6.29B 6.22B 6.95B -109M
Total Current Liabilities 23.67B 22.15B 24.05B 22.49B
Total Liab 57.76B 59.62B 61.34B 54.39B
Common Stock 1.35B 1.35B 1.35B 1.34B
Retained Earnings 8.75B 7.29B 5.05B -2.7B
Treasury Stock 1.66B 2.67B 1.83B 2.05B
Capital Surplus 3.3B 3.28B 3.17B 3.09B
Other Stockholder Equity 1.66B 2.67B 1.83B 2.05B
Total Stockholder Equity 15.05B 14.59B 11.4B 3.78B
Net Tangible Assets -25.58B -25.83B -30.11B -19.21B

Cash Flow Statement

Cash Flow Statement history of GSK plc (LSE:GSK)

31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net Income 4.38B 5.75B 4.64B 3.62B
Depreciation 2.15B 2.11B 2.33B 1.86B
Change To Netincome 993M -838M 769M 3.17B
Change To Account Receivables -782M -224M -32M -429M
Change To Liabilities 284M 225M 263M 131M
Change To Inventory 25M 119M 300M 51M
Change To Operating Activities 670M 1.06B -259M 18M
Total Cash From Operating Activities 7.95B 8.44B 8.02B 8.42B
Capital Expenditures -1.17B -1.23B -1.26B -1.34B
Investments 334M 2.85B -199M -165M
Other Cashflows From Investing Activities 36M 70M 89M 111M
Total Cashflows From Investing Activities -1.78B 2.16B -5.35B -1.55B
Dividends Paid -4B -3.98B -3.95B -3.93B
Net Borrowings -2.21B -4.23B 3.52B 8.12B
Other Cashflows From Financing Activities -1.4B -1.95B -1.45B -10.66B
Total Cash From Financing Activities -7.59B -10.13B -1.84B -6.39B
Effect Of Exchange Rate -29M -39M -82M 8M
Change In Cash -1.44B 431M 744M 487M
Issuance Of Stock 21M 29M 51M 74M